VanEck Vectors Biotech ETF news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

BBH 129.59 -2.15 (-1.63%)
price chart
131.71
VanEck Vectors Biotech ETF. Watchlist CreateBBHAlert. Open. Last Updated: Jul 24, 2017 11:44 a.m. EDT Real time quote. $ 131.71. 0.27 0.21%. Previous Close. $131.4400. Created with Highstock 2.1.8 10am 11am 12pm 1pm 2pm 3pm 4pm $130.0 $130.5 ...
Biotech: Is Capitulation Near?
It has been a rough ride for biotech investors during October, with small cap concerns particularly getting clobbered during the month.
Biotech ETFs fall as Trump says more bidding needed on drugs
"They're getting away with murder," Trump said of drug companies at a news conference. The iShares Nasdaq Biotechnology ETF IBB, +1.43% fell 2.4% on the day while the SPDR S&P Biotech ETF XBI, +1.16% lost 3.2% and the VanEck Vectors Biotech ETF ...
What Lies Ahead for Biotech ETFs in Trump Era?
Biotech stocks have been under intense pressure for more than a year now with sector-specific issues like increasing political and media focus on high price tags for new drugs and the changing competitive scenario weighing on the sector.
Generic-drug maker ETF could outperform biotech peers under Clinton
The VanEck Vectors Pharmaceutical ETF PPH, -0.47% fell 0.9% to $51.58 on Tuesday, while the VanEck Vectors Biotech ETF BBH, +0.84% rose 0.8% to $105.51.
5 Reasons Why Biotech ETFs are Soaring
The biotech sector is going through the roof right now with SPDR S&P Biotech ETF XBI adding over 9.4% in the last five days (as of June 21, 2017).
Trader's Daily Notebook: Market's All Over the Map  TheStreet.com
Time to Buy Biotech ETFs?
2016 was a tough year for biotech stocks with the sector facing a lot of criticism for rising drug prices. Although shares did rally post-election in November on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the ...
Opinion: What pharma investors ought to do after Donald Trump fires a salvo
So consider selling these seven ETFs: PowerShares Dynamic Pharmaceuticals Portfolio ETF PJP, +1.00% iShares U.S. Pharmaceuticals ETF IHE, +1.29% SPDR S&P Pharmaceuticals ETF XPH, +1.24% VanEck Vectors Pharmaceutical ETF PPH, +1.16% iShares Nasdaq ...
Why Biotech Stocks Are Hitting the Skids (FBT, IBB)
Biotech ETFs are down significantly since the House of Representatives passed a health care bill last week, the Wall Street Journal reports.
Biotech ETF Industry Outlook for Second Half 2017
Biotech stocks have had a strong run so far in 2017 with the NASDAQ Biotechnology Index soaring 19.4% year-to-date (YTD).